Account wins

Share this article:
Shire Pharmaceuticals tapped InVentiv's Palio to handle professional advertising and promotion for Fosrenol, which is indicated for hyperphosphatemia in patients with end stage renal disease. Surge Healthcare previously handled the account.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions